Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-02 4:20 pm Purchase | 2025-03-26 | 13G | Surrozen, Inc. SRZN | 5AM Partners VII, LLC | 908,387 9.900% | 908,387 (New Position) | Filing History |
| 2024-12-19 6:09 pm Sale | 2024-12-17 | 13D | Skye Bioscience, Inc. SKYE | 5AM Partners VII, LLC | 11,696,895 36.400% | -207,168 (-1.74%) | Filing History |
| 2024-11-14 5:48 pm Sale | 2024-09-30 | 13G | Dianthus Therapeutics, Inc. DNTH | 5AM Partners VII, LLC | 1,027,711 3.500% | -654,873 (-38.92%) | Filing History |
| 2024-03-13 7:28 pm Purchase | 2024-03-13 | 13D | Skye Bioscience, Inc. SKYE | 5AM Partners VII, LLC | 11,904,063 40.000% | 457,499 (+4.00%) | Filing History |
| 2024-02-14 4:16 pm Purchase | 2023-12-31 | 13G | Dianthus Therapeutics, Inc. DNTH | 5AM Partners VII, LLC | 1,682,584 5.700% | 200,264 (+13.51%) | Filing History |
| 2024-01-31 4:15 pm Purchase | 2024-01-29 | 13D | Skye Bioscience, Inc. SKYE | 5AM Partners VII, LLC | 11,446,564 44.200% | 11,446,564 (New Position) | Filing History |
| 2023-09-21 4:15 pm Purchase | 2023-09-11 | 13G | Dianthus Therapeutics, Inc. DNTH | 5AM Partners VII, LLC | 1,482,320 10.000% | 1,482,320 (New Position) | Filing History |
| 2023-08-28 4:16 pm Purchase | 2023-08-18 | 13D | Skye Bioscience, Inc. SKYE | 5AM Partners VII, LLC | 6,228,821 44.400% | 6,228,821 (New Position) | Filing History |